Some employers view evidence-based obesity treatment as a long-term investment in workforce health
showed that females presented a higher risk of developing L-C19 symptoms such as dyspnea, fatigue, breathlessness, chest pain, palpitations, depression, sleep disorders, hair loss, ocular problems, and GI-related problems than men (146)
GLP-1 and hair loss Some patients taking GLP-1 drugs also report hair loss
They engage GHRH receptors on pituitary somatotroph cells and support the signaling pathway normally activated by hypothalamic GHRH
These strategies are drawn from Eli Lilly's prescribing information, peer-reviewed GI literature, and pharmacist-reviewed drug references